Qube Research & Technologies Ltd - PARATEK PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$30,551
-63.4%
12,028
-73.0%
0.00%
Q4 2022$83,424
-18.2%
44,612
+12.2%
0.00%
-100.0%
Q3 2022$102,000
+18.6%
39,762
-10.5%
0.00%0.0%
Q2 2022$86,00044,4490.00%
Other shareholders
PARATEK PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
AIGH Capital Management LLC 2,339,107$10,502,0003.20%
Telemetry Investments, L.L.C. 262,279$1,178,0001.52%
Bruce & Co., Inc. 1,443,312$6,480,0001.30%
Omega Fund Management, LLC 1,971,241$8,851,0001.25%
Worth Venture Partners, LLC 556,832$2,500,0001.24%
Abingworth LLP 1,041,131$4,654,0001.13%
1492 Capital Management LLC 491,033$2,205,0001.09%
CM Management, LLC 300,000$1,347,0001.02%
Trellus Management Company, LLC 295,000$1,325,0000.88%
GENERAL AMERICAN INVESTORS CO INC 1,306,919$5,868,0000.46%
View complete list of PARATEK PHARMACEUTICALS INC shareholders